JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Lee, T. J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Lee, T. J.-F.

Vol. 302, Issue 1, 397-405, July 2002


Presynaptic Muscarinic M2-Receptor-Mediated Inhibition of N-Type Ca2+ Channels in Cultured Sphenopalatine Ganglion: Direct Evidence for Acetylcholine Inhibition of Cerebral Nitrergic Neurogenic Vasodilation

J. Liu, M. S. Evans and T. J.-F. Lee

Departments of Pharmacology (J.L., T.J.-F.L.) and Neurology (M.S.E.), Southern Illinois University School of Medicine, Springfield, Illinois

    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Results of previous pharmacological studies suggested that presynaptic muscarinic M2 receptors on cerebral perivascular nitric oxidergic (nitrergic) nerves mediated inhibition of nitric oxide release from these nerves. The inhibition was thought to be primarily attributable to a decreased Ca2+ influx through N-type Ca2+ channels on nitrergic nerves, but direct evidence supporting this hypothesis was not presented. In the present study, we used cultured rat sphenopalatine ganglion (SPG), a major source of nitrergic nerves to cerebral blood vessels, to investigate the role of muscarinic M2 receptors in modulating voltage-dependent Ca2+ channels. SPG neuronal soma and dendrites were immunoreactive for both N-type Ca2+ channels and muscarinic M2 receptors, indicating that muscarinic M2 receptors were colocalized with N-type Ca2+ channels. Using the whole-cell voltage-clamp technique, we found that voltage-dependent Ca2+ currents in cultured SPG were largely blocked by omega -conotoxin, an N-type calcium channel antagonist, but were not affected by nifedipine, an L-type calcium antagonist. The Ca2+ current was inhibited by acetylcholine (ACh) and arecaidine but-2-ynyl ester tosylate (ABET), a preferential muscarinic M2-receptor agonist, in a concentration-dependent manner. The inhibition was reversed by atropine and methoctramine (a muscarinic M2-receptor antagonist), but was not affected by muscarinic M1-, M3-, or M4-receptor antagonists. Consistent with this, preferential muscarinic M1-receptor agonists McN-A-343 and oxotremorine did not affect the Ca2+ current. Furthermore, pretreatment with pertussis toxin and guanosine 5'-O-(3-thio)triphosphate prevented ACh and ABET inhibition of Ca2+ currents. These results are consistent with pharmacological findings in the pig basilar arteries and provide direct evidence supporting our hypothesis that M2-receptor-mediated inhibition of cerebral nitrergic neurogenic vasodilation is due to a Gi-protein-mediated suppression of Ca2+ influx via voltage-dependent N-type Ca2+ channels on perivascular nerves.

    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The large cerebral arteries of several species such as dog, pig, cow, and monkey have been shown to receive dense cholinergic innervation (Lee, 1994). At one time, it was assumed that ACh acted as the transmitter for cerebral neurogenic vasodilation. This assumption was questioned when the vasodilation in isolated cat cerebral arterial rings induced by electrical stimulation of the perivascular nerves was not blocked by atropine (Lee et al., 1975; Lee, 1980). It is now clear that nitric oxide (NO), which is released from cholinergic-nitric oxidergic nerves (Kimura et al., 1997), is the major transmitter mediating cerebral neurogenic vasodilation (Toda and Okamura, 1990; Lee and Sarwinski, 1991; Gonzalez et al., 1992). ACh released from these nerves has been suggested to act as a presynaptic modulator (Lee, 1986; Ayajiki et al., 1993) or transmitter (Liu and Lee, 1999) in inhibiting NO release. Our previous studies using in vitro tissue bath techniques demonstrated that ACh inhibition of NO-mediated neurogenic vasodilation in porcine cerebral arteries was mediated by activation of presynaptic muscarinic M2 receptors located on perivascular nitrergic nerves, possibly resulting in suppression of voltage-dependent Ca2+ channels on those nerves (Liu and Lee, 1999). Because the Ca2+ influx from the voltage-dependent Ca2+ channels is crucial in activating the Ca2+-dependent NO synthase (NOS) in neurons (Boeckxstaens et al., 1993), suppression of these channels leads to a decreased NO formation and release from these nerves. Direct evidence for inhibition of voltage-dependent Ca2+ channel by activation of muscarinic receptors in the cerebral perivascular nerves, however, has not been presented.

Although inhibition of voltage-dependent Ca2+ channels by muscarinic agonists has been reported in several types of neurons in the central and peripheral nervous systems (Mochida and Kobayashi, 1986; Wanke et al., 1987; Beech et al., 1992; Bernheim et al., 1992; Allen and Brown, 1993; Cuevas and Adams, 1997; Jeong and Wurster, 1997), direct demonstration of a muscarinic effect on Ca2+ channels in the perivascular nerves is technically formidable because of difficulty in using patch-clamp techniques on these nerves. Because the major portion of cerebral perivascular nitrergic nerves originates in the sphenopalatine ganglion (SPG) in many species including cat, pig, and rat (Hara et al., 1989; Suzuki et al., 1990; Nozaki et al., 1993; Suzuki and Hardebo, 1993; Minami et al., 1994; Kadota et al., 1996; Kimura et al., 1997; Yu et al., 1997), the present study was designed to determine the role of muscarinic receptors in inhibiting voltage-dependent Ca2+ channels in the cultured adult rat SPG by using whole-cell patch-clamp recording. We already have shown that cultured adult rat SPG neurons (both soma and dendrites) are similar to cerebral perivascular nerves of the pig in their immunohistochemical, pharmacological, and electrophysiological characteristics (Liu et al., 2000). Specifically, both soma and dendrites of the cultured rat SPG contain N-type Ca2+ channels, which are the dominant voltage-dependent Ca2+ channels in regulating Ca2+ influx during membrane depolarization (Liu et al., 2000).

For comparison, the in vitro tissue bath technique was used also to continue examination of presynaptic muscarinic receptors in modulating NO-mediated neurogenic vasodilation in porcine cerebral arterial rings (Liu and Lee, 1999).

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Isolation and Culture of Rat SPG Neurons. These were carried out according to methods in our previous report (Liu et al., 2000). Sprague-Dawley rats (3 to 16 weeks old) were anesthetized with sodium pentobarbital (50 mg/kg, i.p.). The sphenopalatine ganglia of both sides were dissected (Spencer et al., 1990; Liu et al., 2000) and were placed in cold Hibernate A (Invitrogen, Carlsbad, CA) solution. Ganglia were cut into smaller pieces; transferred to Mg2+- and Ca2+-free Hanks' balanced salt solution (Invitrogen) containing papain (2 U/ml; Sigma-Aldrich, St. Louis, MO), collagenase D (0.6 mg/ml; Roche Applied Science, Indianapolis, IN), and Dispase (2.4 mg/ml, Invitrogen); and then incubated for 40 min at 37°C. Cells were released by gentle trituration at the end of the incubation. The cell suspension was centrifuged at 300g for 5 min. The pellet was gently resuspended in neurobasal culture medium (Invitrogen), containing B27 (1:50 dilution, Invitrogen), 0.5 mM L-glutamine, 25 µM L-glutamate and 50 ng/ml nerve growth factor (Alomome Laboratories Ltd, Jerusalem, Israel) (Brewer et al., 1993; Liu et al., 2000). All medium and Hanks' balanced salt solution contained 100 U/ml penicillin and 100 U/ml streptomycin (Invitrogen). The cell suspension was plated into a 24-well culture plate with a poly-D-lysine coated (50 µg/ml, Sigma-Aldrich) glass coverslip (12-mm diameter; Carolina Biological Supply Co., Burlington, NC) in each well and incubated with air containing 5% CO2 at 37°C. The growth medium was changed every 6 days.

Immunocytochemistry. SPG neurons cultured for 1 to 3 weeks were fixed in 4% paraformaldehyde for 20 to 60 min at room temperature or overnight at 4°C. After rinsing three times with PBS (pH 7.4), cells were permeabilized and nonspecific sites were blocked with 5% normal goat serum in 0.2% Triton X-100 PBS for 1 h at room temperature. After rinsing once, the cells were incubated simultaneously with anti-M2 muscarinic receptor antibody and anti-alpha 1b-subunit of voltage-gated Ca2+ channel (N-type Ca2+ channel) antibody at room temperature overnight. The anti-M2-receptor antibody was a monoclonal antibody raised from rat (Chemicon; 1:100 dilution). The anti-alpha 1b-subunit of voltage-gated Ca2+ channel antibody was a polyclonal antibody raised from rabbit (1: 200 dilution; Alomone Laboratories). The antibodies were diluted in 0.05% Triton X-100/PBS/1.5% NGS. After incubation with the primary antibodies, the cells were rinsed with PBS three times before incubating with secondary antibodies. The secondary antibodies were fluorescein-conjugated anti-rabbit IgG (1:40 dilution; Vector Laboratories, Burlingame, CA) or rhodamine-conjugated anti-rat IgG (1:40 dilution; Jackson Immunoresearch Laboratories, Inc., West Grove, PA). After 1-h incubation with second antibodies at room temperature, cells were rinsed with PBS (pH 8.2) three times and mounted in Vectashield mounting medium (Vector Laboratories). The stained cells were observed and photographed first under a fluorescence microscope (BX50 microscope; Olympus, Tokyo, Japan) fitted with a fluorescein filter. Without changing field, cells were photographed for the second time using a rhodamine filter. Negative controls were obtained following the same incubation procedure with neutralized serum by corresponding antigen (Liu et al., 2000).

Electrophysiology. Electrophysiological study using patch-clamp recording was carried out as described previously (Liu et al., 2000). In brief, a glass coverslip containing cultured neurons was transferred from the growth medium to a 35-mm plastic Petri dish containing the extracellular recording solution (described below; Liu et al., 2000) on a phase-contract microscope (Olympus IMT2). The calcium currents were recorded in the whole-cell configuration of the patch-clamp technique (Hamill et al., 1981; Liu et al., 2000) at room temperature. Patch electrodes were pulled from 1.5-mm outer diameter with 1.0-mm inner diameter capillary glass (World Precision Instruments PG52151-4), and the tips were then fire-polished. After filling with intracellular solution (described below; Liu et al., 2000), electrode impedance in the extracellular recording solution was 3 to 4 megohms. This component of the series resistance was fully compensated using the bridge balance control of the Axoclamp 2B (Axon Instruments) used for recording. The electrode tip potential was also subtracted while in bridge mode. Tight seals of at least 2 gigaohms, but usually 5 to 10 gigaohms were obtained by light suction. Electrode series resistance increased to 6 to 8 megohms after entry into whole-cell mode but was not further compensated. Voltage protocol generation and data acquisition were performed using pClamp software (Axon Instruments, Foster City, CA) and a digital data acquisition system (Digidata 1200). To evoke calcium currents, test pulses to 0 mV for 100 ms were applied every 15 s from a -70 mV holding potential in the absence or presence of drugs. The current traces were low-pass filtered at 3 kHz and digitized at 20 kHz. The resistive and capacitative components of the leak current were subtracted using a P/4 procedure (Armstrong and Bezanilla, 1974; Evans et al., 1998). Data were stored in a computer hard drive for later analysis. The concentration that produced 50% inhibition of maximal relaxation or peak Ca2+ currents (EC50) were calculated for each preparation. From these values, the geometric means for EC50 with 95% confidence intervals were calculated (Fleming et al., 1972).

In Vitro Tissue Bath Study on Neurogenic Vasodilation in Porcine Basilar Arterial Rings. Fresh heads of adult pigs of either sex were collected from a local slaughterhouse. The entire brain was removed and placed in a Krebs-bicarbonate solution equilibrated with 95% O2-5% CO2 at room temperature. Basilar arteries were dissected and cleaned of surrounding tissue under a dissecting microscope. The ring segment (4 mm long), with endothelium mechanically denuded (Lee, 1982), was cannulated with a stainless steel rod (30-gauge hemispherical section) and a short piece of platinum wire and mounted in a tissue bath containing 6 ml of Krebs-bicarbonate solution equilibrated with 95% O2-5% CO2 at 37°C. Tissues were equilibrated in the Krebs-bicarbonate solution for 30 min and then were mechanically stretched to a resting tension of 0.75g for another 30 min. U-46619 (0.1-1 µM) was then applied to induce an active muscle tone of about 0.75g. Tissues were electrically and transmurally stimulated with a pair of platinum electrodes through which 100 biphasic square-wave pulses of 0.6 ms in duration and 200 mA in intensity were applied at various frequencies (Lee, 1982). The neurogenic origin of this TNS-induced response was verified by its complete blockade by 1 µM TTX. Papaverine (300 µM) was applied to each tissue at the end of the experiment to induce maximal relaxation. The magnitude of a vasodilator response was expressed as a percentage of the maximal response induced by papaverine (Lee, 1982).

Drugs were added directly to the tissue bath after control relaxation induced by TNS was established. The concentrations of drugs reported were the final concentrations in the bath. TNS was elicited 15 min after each experimental drug was added. Each tissue preparation served as its own control.

Solutions, Drugs Used, and Statistical Methods. The Krebs-bicarbonate solution for tissue bath contained 122.0 mM NaCl, 5.2 mM KCl, 1.33 mM CaCl2, 1.2 mM MgSO4, 25.0 mM NaCO3, 0.03 mM disodium EDTA, 0.01 mM L-ascorbic acid, and 11.0 mM glucose (pH 7.4). Extracellular solution for Ca2+ current recording contained 130 mM NaCl, 3 mM KCl, 1 mM MgCl2, 5.0 mM barium chloride (or 2.5 mM CaCl2), 25 mM dextrose, and 10 mM MOPS (pH 7.25). Intracellular solution for Ca2+ current recording contained 140 mM cesium methane sulfonate, 1 mM MgCl2, 5 mM EGTA, 10 mM HEPES, 2 mM MgATP, and Na3GTP (pH 7.25).

The following drugs were used: acetylcholine chloride (ACh), atropine, nitro-L-arginine (L-NNA), L-arginine, tetrodotoxin (TTX), U-46619, 8-bromoadenosine 3',5'-cyclic monophosphate (8-bromo-cAMP), nitroblue tetrazolium, and guanosine 5'-O-(3-thio)triphosphate (GTPgamma S) (all from Sigma-Aldrich); physostigmine, tropicamide, 4-DAMP mustard HCl, methoctramine HCl, McN-A-343, oxotremorine M, pirenzepine, omega -conotoxin GVIA, and pertussis toxin (all from Sigma/RBI, Natick, MA); arecaidine but-2-ynyl ester tosylate (ABET) and MR16728 hydrochloride (Tocris Cookson, St. Louis, MO).

The data obtained from the tissue bath study were computed as means ± S.E.M. and were evaluated by Student's t test for paired samples and analysis of variance for multigroup comparisons. The data obtained from electrophysiological studies were computed as means ± S.D. and were evaluated by Student's t test.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Effect of ACh on Ca2+ Channel Currents in Cultured Rat SPG Neurons. ACh (0.1-1 µM) significantly inhibited the peak Ca2+ currents in most cultured SPG neurons (34 of 37 tested neurons). A 100-ms voltage step to 0 mV from holding potential -70 mV evoked a slowly inactivating inward Ca2+ current, which was largely inhibited in the presence of 1 µM ACh in the bath solution (Fig. 1A). The inhibition was observed in the tail current as well (Fig. 1A). The current-voltage (I-V) curve from -60 to +60 mV showed that ACh-induced inhibition occurred at all voltages (Fig. 1B). In a current versus time plot, which reflects the real time course of the recording, the inhibition of the Ca2+ currents by ACh was fast, concentration dependent, and atropine reversible (Fig. 1C). The concentration-response curve shows that the maximal inhibition is 63.1 ± 5.6% with EC50 values of 2.8 (1.1-7.2) µM (Fig. 1D).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of ACh on Ca2+ channel current in cultured SPG neurons of the rat. A, Ca2+ channel current evoked in response to a depolarizing step from holding potential of -70 to 0 mV in the absence (control) and presence of 1 µM ACh. B, whole-cell I-V relationship of peak Ca2+ channel current in the absence (open circle ) and presence () of 1 µM ACh. C, peak Ca2+ channel current amplitude () plotted as a function of time when 0.1 and 1 µM ACh and 3 µM atropine were successively applied to the bath as indicated. The peak Ca2+ channel currents were evoked every 15 s by a depolarizing step to 0 mV from holding potential -70 mV. D, concentration-response curve of Ca2+ channel current inhibition by ACh. Data represent means ± S.D. and n indicates number of tested cells.

The inhibition of Ca2+ currents produced by 1 µM ACh was reversed also by 1 µM methoctramine, a muscarinic M2-receptor antagonist (Fig. 2B). However, it was not affected by pirenzepine (a muscarinic M1-receptor antagonist), 4-DAMP (a muscarinic M3-receptor antagonist), or tropicamide (a muscarinic M4-receptor antagonist), even at the concentration as high as 10 µM (Fig. 2, A, C, and D).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of subtype-selective muscarinic receptor antagonists on ACh-induced inhibition of Ca2+ channel current in cultured SPG neurons. With 1 µM ACh in the bath, superimposed Ca2+ channel current elicited by depolarizing steps from -70 to 0 mV in the absence and presence of selective muscarinic receptor antagonists: 0.1 to 10 µM pirenzepine (A), 0.1 to 1 µM methoctramine (B), 0.1 to 10 µM 4-DAMP (C), and 0.1 to 10 µM tropicamide (D). Only methoctramine reversed ACh-induced inhibition of Ca2+ channel current.

Effects of Cholinergic Agents on NO-Mediated Neurogenic Vasodilation in Porcine Basilar Arteries. Porcine basilar arterial rings denuded of endothelial cells in the presence of active muscle tone induced by U-46619 exclusively relaxed upon TNS at 2 Hz (Fig. 3A). The TNS-elicited vasodilation was significantly enhanced by 0.1 µM atropine. The enhanced vasodilation was completely inhibited by 30 µM L-NNA and reversed by L-arginine. The LNNA- and TTX-sensitive TNS-elicited neurogenic vasodilation, however, was inhibited by exogenous 1 µM ACh and 1 µM ABET, a muscarinic M2-receptor agonist (Fig. 3B). These results were reproducible in the basilar arteries from 20 pigs and were consistent with results reported previously (Liu and Lee, 1999).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of muscarinic agonists and antagonist on NO-mediated, TNS-elicited neurogenic vasodilation in porcine basilar arteries. A, a representative tracing of relaxation in a porcine basilar artery without endothelial cells elicited by TNS at 2 Hz. The active muscle tone in the arterial ring was induced by 0.3 µM U-46619. The TNS-elicited relaxation was enhanced by atropine and abolished by L-NNA. The inhibition was reversed by L-arginine (L-Arg). The relaxation was abolished by TTX. B, a representative tracing showing that vasodilation induced by TNS at 2 Hz was decreased in the presence of 1 µM ACh or 1 µM ABET.

Comparable Effects of Preferential Muscarinic M1 and M2 Agonists on Ca2+ Channel Currents in Rat SPG Neurons and Porcine Cerebral Neurogenic Vasodilation. In porcine basilar arteries, ABET significantly inhibited TNS (2 Hz)-elicited neurogenic vasodilation, with EC50 values of 0.5 (0.1-2.5) µM and maximal inhibition of 52.2 ± 11.0% (n = 6; Fig. 4A). On the other hand, McN-A-343, a preferential muscarinic M1-receptor agonist, inhibited TNS (2 Hz)-elicited neurogenic vasodilation with lower efficacy (maximal inhibition was 36.0 ± 12.5%; n = 6) and significantly higher EC50 values (>10 µM) (Fig. 4A).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of preferential muscarinic M1- and M2-receptor agonists on cerebral neurogenic vasodilation (A) and Ca2+ channel currents in the SPG neurons (B). A, effect of different concentrations of McN-A-343 and ABET on TNS (2 Hz)-elicited neurogenic vasodilation in porcine basilar arteries without endothelial cells. ABET is more potent than McN-A-343 in blocking relaxation induced by TNS. B, effects of different concentrations of ABET, McN-A-343, and oxotremorine (Oxo-M) in inhibiting Ca2+ channel current in the cultured SPG. The Ca2+ channel current was the peak current elicited by a depolarization step from -70 to 0 mV. All data represent means ± S.D.M. n represents number of cells varying from six to eight in each point.

In cultured rat SPG neurons, ABET concentration dependently inhibited Ca2+ channel currents with a maximal inhibition of 65.9 ± 4.4% and EC50 values of 3.6 (1.0-12.5) µM (Fig. 4B). On the other hand, McN-A-343 and oxotremorine (up to 1 mM), another preferential muscarinic M1-receptor agonist, did not significantly affect Ca2+ channel currents (Fig. 4B).

Colocalization of Muscarinic M2 Receptors and N-Type Ca2+ Channels in the Rat SPG Neurons. Results from double-labeling immunocytochemical study indicated that the cultured rat SPG neurons (1-3 weeks) were immunoreactive for both N-type Ca2+ channels and muscarinic M2 receptor (Fig. 5, A and B). The N-type Ca2+ channel immunoreactivity was labeled with fluorescein isothiocyanate (A) and muscarinic M2-receptor immunoreactivity with rhodamine (B). Both N-type Ca2+ channel- and muscarinic M2-receptor immunoreactive fibers including soma and dendrites were completely coincident. In negative control, neurons were not immunoreactive to the antigen preabsorbed N-type Ca2+ channel antibodies or muscarinic M2-receptor antibodies (data not shown).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 5.   Colocalization of M2 receptors and N-type Ca2+ channels in a cultured SPG neuron of the rat. A, a cultured SPG neuron (14th day) was immunoreactive to fluorescein isothiocyanate-conjugated N-type Ca2+ channel antibodies. The cell was photographed using the fluorescein isothiocyanate filter (BA515; Olympus). B, the cell in A was also immunoreactive to rhodamine-conjugated M2-receptor antibodies. The cell was photographed using the rhodamine filter (BA590; Olympus). The bar represents 25 µm.

Effect of CTX on Muscarinic Inhibition of Ca2+ Channel Currents in the Rat SPG Neurons. Previous pharmacology studies demonstrated that TNS-elicited neurogenic vasodilation in porcine basilar arteries was significantly inhibited by 0.1 µM omega -conotoxin, a selective N-type Ca2+ channel blocker. In the presence of the inhibition produced by CTX, the residual vasodilation was not further inhibited by ABET or enhanced by atropine (Liu and Lee, 1999). Consistent with this report, 1 µM omega -conotoxin, but not 0.1 mM nifedipine (a selective L-type Ca2+ channel blocker), largely inhibited Ca2+ currents in SPG neurons. In the presence of 1 µM omega -conotoxin, the residual Ca2+ current was not affected by 10 µM ACh or 10 µM ABET (Fig. 6, A and B, n = 4).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of omega -conotoxin on muscarinic receptor-mediated inhibition of Ca2+ channel current in cultured SPG neurons. A, peak Ca2+ channel current amplitude () plotted as a function of time when 10 µM ABET and 10 µM ACh were applied in the presence of 1 µM omega -conotoxin in the bath. The peak Ca2+ channel currents were evoked every 15 s by a depolarizing step to 0 mV from holding potential -70 mV. B, a summary of peak amplitude of Ca2+ channel currents inhibited by 1 µM CTX. The difference between CTX and control group is significant (*, p < 0.01). There is no significant difference among CTX, CTX + ACh, and CTX + ABET groups (p > 0.05). Data represent means ± S.D. n indicates number of cells examined.

Effect of 8-Bromo-cAMP on Muscarinic Inhibition of Ca2+ Channel Currents in the Rat SPG Neurons. Because muscarinic M2-receptor-mediated effects often are coupled to a decrease in intracellular cAMP, 8-bromo-cAMP, a membrane permeable cAMP analog, was used to examine the involvement of cAMP in the muscarinic inhibition of Ca2+ channels. In cultured rat SPG neurons, 1 to 10 mM 8-bromo-cAMP did not affect the peak Ca2+ currents (n = 3, data not shown), nor did it affect ACh-induced inhibition of Ca2+ currents, which, however, were reversed by atropine (n = 6, Fig. 7).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of 8-bromo-cAMP on muscarinic receptor-mediated inhibition of Ca2+ channel current in cultured SPG neurons. Peak Ca2+ channel current amplitude () plotted as a function of time when 1 µM ACh, 1 to 10 mM 8-bromo-cAMP, and 10 µM atropine were successively applied to the bath as indicated. The peak Ca2+ channel currents were evoked every 15 s by a depolarizing step to 0 mV from holding potential -70 mV.

Effect of Pertussis Toxin (PTX) on Muscarinic Inhibition of Ca2+ Channel Currents in the Rat SPG Neurons. Because muscarinic M2 receptors are coupled to Gi/o protein, PTX, which uncouples Gi/o protein from receptors by ADP ribosylation (West et al., 1985), was used to examine the involvement of G proteins in inhibition of Ca2+ currents in the SPG neurons. PTX (1 µg/ml) was added to the cell culture dish 24 to 36 h before patch-clamp recording. High concentration (10 µM) of ACh was used to produce the maximal inhibition of Ca2+ currents. In control SPG neurons (n = 8), the maximal inhibition produced by ACh was 64.5 ± 5.8%. In PTX-pretreated SPG neurons (n = 9), the maximal inhibition however was 19.4 ± 16.4% (n = 9). The difference of the maximal inhibition of Ca2+ currents between the PTX-treated and untreated neuron was significant (p < 0.01; Fig. 8).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 8.   Summary of the maximal inhibition of Ca2+ channel current in the SPG neurons in the absence (control) and presence of PTX-pretreatment. PTX (1 µg/ml) was added to cultured SPG neurons 24 to 36 h before recording. Ca2+ channel currents were elicited by depolarizing steps from -70 mV to 0 mV. Maximal inhibition of peak Ca2+ channel currents was produced by 10 µM ACh. Data represent means ± S.D. Number of tested cells in each group is indicated in parentheses. *, p < 0.01 indicates significant difference from control.

Effect of GTPgamma S on Muscarinic Inhibition of Ca2+ Channel Currents in the Rat SPG Neurons. To further investigate the involvement of G protein in M-receptor-mediated inhibition of Ca2+ currents in the SPG neurons, GTPgamma S was used to replace GTP in the intracellular recording solution in some studies. GTPgamma S, a nonhydrolyzable GTP analog, binds tightly to the alpha -subunit of G proteins and confers a receptor-independent, irreversible G protein action. When GTPgamma S was present in the intracellular solution, the Ca2+ currents in all recorded SPG neurons were rapidly depressed without adding muscarinic agonist. After 10 min of dialysis, the residual current was 28.3 ± 5.5% of the original current, and no further inhibition induced by ACh was observed in the majority of the neurons examined (seven of nine) (Fig. 9, A and B). The inhibition of Ca2+ currents produced by 10 µM ACh in two neurons was small and was not reversed by atropine (data not shown).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 9.   Effects of GTPgamma S on muscarinic receptor-mediated inhibition of Ca2+ channel current in cultured SPG neurons. Peak Ca2+ channel current amplitude () plotted as a function of time when ACh was applied to the bath after 10 min of internal dialysis of GTPgamma S (A) as indicated. GTPgamma S (0.5 mM) was used instead of GTP in the intracellular solution. The peak Ca2+ channel currents were evoked every 30 s by a depolarizing step to 0 mV from holding potential -70 mV. ACh was added when no more significant decrease of current was seen (usually around 10 min after whole-cell formation). B, summary of the inhibition of peak Ca2+ channel currents by 10 µM ACh in the absence and presence of GTPgamma S in the intracellular solution. The currents were recorded 10 min after GTPgamma S dialysis. Data represent means ± S.D. n indicates number of tested cells.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Atropine has been shown to increase NO-mediated cerebral neurogenic vasodilation in several species including the pig (Liu and Lee, 1999), cow (Ayajiki et al., 1993), and monkey (Toda et al., 1997). This effect of atropine has been suggested to be caused by blockade of presynaptic muscarinic receptors, thereby blocking the inhibitory effect of endogenously released ACh on NO release (Ayajiki et al., 1993; Liu and Lee, 1999) from perivascular cholinergic-nitrergic nerves (Kimura et al., 1997; Yu et al., 1998). Our results found in porcine cerebral arteries further suggested that the inhibitory effect of ACh was mediated by presynaptic M2 receptors, which were coupled to suppression of N-type Ca2+ channels (Liu and Lee, 1999). In the present study, we further demonstrated that ACh and ABET (a muscarinic M2-receptor agonist) inhibited NO-mediated neurogenic vasodilation in porcine cerebral arterial rings and provided new evidence that these two muscarinic agonists inhibited N-type Ca2+ currents in the rat SPG neurons, which are partial sources of cerebrovascular nitrergic nerves. These similar results found in the pig and rat support our hypothesis that ACh inhibits neurogenic vasodilation by suppressing Ca2+ influx through N-type Ca2+ channels on nitrergic nerves, thereby causing decreased formation and release of NO and diminished vasodilation (Fig 10).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 10.   A diagram showing a cholinergic-nitrergic nerve terminal innervating large cerebral arteries at the base of the rat and pig brain. NO, which is not stored in vesicles, is Colocalized and co-released with ACh (), which is stored in the vesicles. NO is synthesized from L-arginine (L-Arg) in the presence of nitric-oxide synthase (NOS). L-citrulline (L-Cit), the byproduct of NO synthesis, is converted to argininosuccinate (AS) in the presence of argininosuccinate synthase (ASS) and is further converted to L-Arg by argininosuccinate lyase (ASL) (Yu et al., 1997). This L-Cit-L-Arg cycle for continuing production of NO (Chen and Lee, 1995) provides direct evidence for the neuronal source of NO. The neuronal NO plays a major role in cerebral neurogenic vasodilation, which is mediated by activation of guanylate cyclase (GC) and cGMP synthesis in the smooth muscle cell (SMC). ACh released from cholinergic-nitrergic nerves acts on presynaptic muscarinic M2 receptors (M2R) resulting in Gi-protein-mediated negative coupling (-) to the N-type Ca2+ channels (N-Ca2+ch). This leads to suppression of Ca2+ influx through this type of Ca2+ channels and decreased NOS activity accompanied by a decrease in NO formation and release and diminished relaxation of the smooth muscle cell. The endogenous ACh is not a postsynaptic transmitter because it does not directly affect the SMC tone (Lee, 1982). +, indicates activation.

Muscarinic Inhibition of Neurogenic Vasodilation in Cerebral Arteries. Electrical stimulations of perivascular nerves exclusively cause vasodilation in the large cerebral arteries at the base of the brain of several species including the pig (Lee, 1994). The vasodilation is mediated mainly by NO (Lee, 1994; Zhang et al., 1998). In our previous and the present studies, the increase in neurogenic vasodilation by atropine was completely abolished by L-NNA, an NOS inhibitor, and fully recovered by further application of L-arginine, the precursor of NO synthesis. Because atropine did not affect the vasodilation produced by sodium nitroprusside, an NO donor (data not shown), the enhancement of neurogenic vasodilation induced by atropine was most likely attributable to its presynaptic inhibition of muscarinic receptors resulting in increased NO release. That is, atropine antagonizes the tonic inhibition by endogenous ACh of NO release (Ayajiki et al., 1993; Liu and Lee, 1999) because both ACh and NO are co-released in the perivascular cholinergic-nitrergic nerves (Kimura et al., 1997; Yu et al., 1998). Further pharmacological and immunocytochemical studies have shown that the muscarinic M2 receptor is the specific subtype located on the nitrergic nerves mediating the inhibition of neurogenic vasodilation induced by ACh in porcine cerebral arteries (Liu and Lee, 1999). This is further supported by results of the present study.

The release of neuronal NO and subsequent vasodilation have been shown to be Ca2+ dependent (Boeckxstaens et al., 1993). omega -Conotoxin, which is a selective blocker of neuronal N-type Ca2+ channels, largely inhibits NO-mediated neurogenic vasodilation. This result suggests that Ca2+ influx through the N-type Ca2+ channels is important for activation of NOS, thereby leading to the synthesis and release of NO from the nitrergic nerves (Boeckxstaens et al., 1993, 1995). In the porcine basilar arteries, omega -conotoxin partially inhibited NO-mediated neurogenic vasodilation (Liu and Lee, 1999). The residual relaxation may be due to NO synthesis activated by Ca2+ influx through non-N-type Ca2+ channels. The omega -conotoxin-insensitive part of neurogenic vasodilation was not affected by either ACh or ABET, nor was it enhanced by atropine (Liu and Lee, 1999). This result suggests that muscarinic M2-receptor-mediated inhibition is targeted on Ca2+ influx mainly through the N-type Ca2+ channels in cerebral perivascular nerves.

Muscarinic M2 Receptors Mediate Inhibition of N-Type Ca2+ Channels in Cultured Rat SPG Neurons. Due to difficulties of using patch clamp on the perivascular nerves, the effects of muscarinic receptor activation or inhibition on voltage-dependent Ca2+ channels were investigated in cultured SPG neurons. The SPG is one of the major sources of cerebral perivascular nitrergic nerves in the rat, cat, and pig (Suzuki and Hardebo, 1993; Kimura et al., 1997; Yu et al., 1998). SPG neurons were obtained from adult rats instead of pigs because of inconsistency in porcine SPG neuronal culture. Cultured rat SPG neurons have been found to contain neurotransmitters and N-type Ca2+ channels like those found in cerebral perivascular nitrergic nerves in whole-mount preparations from the pig (Liu et al., 2000).

In the present study, voltage-dependent Ca2+ currents in cultured SPG neurons was significantly inhibited by ACh in a rapid, reversible, and concentration-dependent manner, which is consistent with the previous findings in other types of neurons from central and peripheral systems (Mochida and Kobayashi, 1986; Gahwiler and Brown, 1987; Wanke et al., 1987; Tse et al., 1990; Caulfield, 1991; Beech et al., 1992; Bernheim et al., 1992; Allen and Brown, 1993; Cuevas and Adams, 1997; Jeong and Wurster, 1997; Delmas et al., 1998; Stewart et al., 1999). The muscarinic receptor subtypes responsible for inhibition of Ca2+ channel currents vary in different tissue preparations. For example, muscarinic M2 receptors were reported to mediate Ca2+ channel inhibition in the rat basal forebrain neurons (Allen and Brown, 1993) and adult rat intracardiac neurons (Jeong and Wurster, 1997). However, muscarinic M4 receptors were shown to mediate inhibition of Ca2+ channel currents in neonatal rat intracardiac neurons (Cuevas and Adams, 1997). In the rat superior cervical ganglion, both muscarinic M1 and M4 receptors were involved in the inhibition of Ca2+ channel currents via distinguishable mechanisms (Beech et al., 1992; Bernheim et al., 1992; Delmas et al., 1998). In cultured rat SPG neurons in the present study, the muscarinic receptor subtype that mediated inhibition of Ca2+ currents seemed to be M2 subtype for the following reasons. First, ACh-produced inhibition of Ca2+ channel currents was antagonized by atropine (a nonselective muscarinic receptor antagonist) and methoctramine (a muscarinic M2-receptor antagonist), but was not antagonized by pirenzepine (a muscarinic M1-receptor antagonist), 4-DAMP (a muscarinic M3-receptor antagonist), or tropicamide (a muscarinic M4-receptor antagonist). Second, among the available preferential muscarinic M2-receptor subtype agonist, ABET significantly inhibited Ca2+ channel currents with a concentration-response curve similar to that of ACh (with comparable EC50 and maximal inhibition), and its inhibitory effect was antagonized by atropine and methoctramine. In contrast, McN-A-343 or oxotremorine, two preferential muscarinic M1-receptor agonists, failed to exhibit a significant inhibitory effect on Ca2+ channel currents. Similar results were obtained in porcine basilar arteries that ABET is significantly more potent than McN-A-343 in blocking TNS-elicited neurogenic vasodilation (Fig. 4). Third, the immunocytochemical study demonstrated the existence of muscarinic M2 receptors in cultured adult rat SPG neurons. Thus, the results that muscarinic M2 receptors mediated inhibition of Ca2+ channel currents in the rat SPG neurons are consistent with our previous and present observations in porcine arterial ring preparations using in the vitro tissue bath technique that presynaptic muscarinic M2 receptors mediate inhibition of neurogenic vasodilation in porcine cerebral arteries.

The previous study demonstrated that the major portion of voltage-dependent Ca2+ channel current in cultured rat SPG neurons was CTX-sensitive N-type current (Liu et al., 2000). The channels affected most by muscarinic receptor agonists are likely to be N-type Ca2+ channels. This seems to be true based on the present findings that CTX significantly inhibited Ca2+ channel current by about 60% (Fig. 6B) on the SPG neurons. The remaining CTX-insensitive Ca2+ channel currents was no longer affected by either ACh or ABET. The CTX-insensitive Ca2+ current was not likely to be L-type Ca2+ current because it was also insensitive to nifedipine, an L-type Ca2+ channel blocker (Liu et al., 2000). The nature of the residual Ca2+ current remains to be determined. Results of the present study by Ca2+ channel patch-clamp recording, however, provide direct evidence supporting the hypothesis raised from findings in tissue bath experiments that muscarinic M2-receptor-mediated inhibition of cerebral nitrergic neurogenic vasodilation is via suppression of Ca2+ current from N-type Ca2+ channels (Fig. 10).

Possible Mechanisms of Muscarinic Inhibition of Ca2+ Channel Currents in the Rat SPG Neurons. Although activation of muscarinic M2 receptor is coupled to an inhibition of adenylate cyclase (Ui, 1984; Peralta et al., 1988), a decrease in intracellular cAMP level was not a major factor causing inhibition of cerebral neurogenic vasodilation (Liu and Lee, 1999). This was supported by the present findings that 8-bromo-cAMP did not affect calcium currents, suggesting that cAMP was not the mediator for the muscarinic inhibition of Ca2+ channel current in the SPG neurons. This result is consistent with reports by others that intracellular cAMP is not involved in muscarinic receptor-mediated inhibition of Ca2+ channels (Anwyl, 1991; Dolphin et al., 1991; Allen and Brown, 1993; Jeong and Wurster, 1997), although an unidentified second messenger has been reported to partially mediate the muscarinic inhibition of Ca2+ channels in the superior cervical ganglionic neurons (Bernheim et al., 1991; Hille, 1992).

In most reports, muscarinic receptors mediate inhibition of voltage-dependent Ca2+ channels via PTX-sensitive Gi proteins (Hille, 1994; Dolphin, 1995). This is supported by results of the present finding that preincubation of the SPG neurons with 1 µg/ml PTX prevented the muscarinic M2-receptor-mediated inhibition of Ca2+ channel currents. However, the prevention produced by PTX at concentrations lower than 200 ng/ml was inconsistent, like those reported by some investigators (Beech et al., 1992; Bernheim et al., 1992).

To further investigate the role of G proteins in muscarinic receptor inhibition of voltage-dependent Ca2+ channels, nonhydrolyzable GTP analog, GTPgamma S, was used to interrupt muscarinic M2-receptor-mediated inhibitory effects. In tissue bath study, GTPgamma S failed to affect muscarinic M2-receptor-mediated inhibition of cerebral neurogenic vasodilation, possibly because it is membrane impermeable (Liu and Lee, 1999). In patch-clamp recording in the present study, the presence of 0.5 mM GTPgamma S in the intracellular recording solution caused an inhibition of peak Ca2+ channel currents, and in the presence of GTPgamma S, ACh at concentration up to 10 µM failed to cause any effect on the remaining Ca2+ currents. This result suggests that muscarinic M2-receptor-mediated inhibition of Ca2+ channel current was likely to be a Gi protein-mediated effect; a result similar to those found in other neurons (Wanke et al., 1987; Song et al., 1989; Toselli and Lux, 1989; Anwyl, 1991; Dolphin et al., 1991; Allen and Brown, 1993; Jeong and Wurster, 1997).

In summary, the present pharmacological and electrophysiological study consistently demonstrated that ACh and the muscarinic M2-receptor agonist, ABET, inhibited both NO-mediated cerebral neurogenic vasodilation in isolated porcine cerebral arterial ring preparations and voltage-dependent Ca2+ currents in cultured rat SPG neurons. Because the SPG is a major source of cholinergic-nitrergic nerves to the cerebral blood vessels and because NO and ACh are co-released from cholinergic-nitrergic nerves, the present findings provide direct evidence for the physiological role of ACh in modulating NO release and cerebral vascular tone regulation. Furthermore, the present study demonstrates that the muscarinic inhibition of cerebral nitrergic neurogenic vasodilation is due to a Gi-protein-mediated suppression of Ca2+ influx via voltage-dependent N-type Ca2+ channels in perivascular nerves (Fig. 10).

    Acknowledgments

We thank Jean Long for preparing the manuscript.

    Footnotes

Accepted for publication March 11, 2002.

Received for publication February 12, 2002.

This work was supported by National Institutes of Health Grants HL 27763 and HL 47574, AHA/IHA (9807871), and SIU-CRC/EAM (to T.J.-F.L.) and R29NS34564 (to M.S.E.).

Address correspondence to: Dr. Tony J.-F. Lee, Department of Pharmacology, Southern Illinois University, School of Medicine, P.O. Box 19629, Springfield, IL 62794-9629. E-mail: tlee{at}siumed.edu

    Abbreviations

ACh, acetylcholine; SPG, sphenopalatine ganglion; L-NNA, nitro-L-arginine; TTX, tetrodotoxin; GTPgamma S, guanosine 5'-O-(3-thio)triphosphate; ABET, arecaidine but-2-ynyl ester tosylate; 4-DAMP, 4-diphenylacetoxy-N-methylpiperidine; CTX, omega -conotoxin; 8-bromo-cAMP, 8-bromoadenosine 3',5'-cyclic monophosphate; NO, nitric oxide; NOS, nitric-oxide synthase; PBS, phosphate-buffered saline; MOPS, 3-[N-morpholino]propane-sulfonic acid; PTX, pertussis toxin; U-46619, 9,11-dideoxy-9alpha ,11alpha -epoxymethanoprostaglandin F2alpha ; MR16728, (N-(N'-hexamethylene-imino)-propyl-phenyl-cyclohexyl-methyl acetamide; TNS, transmural nerve stimulation.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/02/3021-0397-0405$03.00
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. Jadhav, A. Jabre, M.-F. Chen, and T. J.-F. Lee
Presynaptic Prostaglandin E2 EP1-Receptor Facilitation of Cerebral Nitrergic Neurogenic Vasodilation
Stroke, January 1, 2009; 40(1): 261 - 269.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Lee, T. J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Lee, T. J.-F.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition